Crabgrass Allergy: The Lawn Weed That Extends Grass Season Into October

Yes, crabgrass (Digitaria sanguinalis and D. ischaemum) can cause seasonal allergic rhinitis through inhalation of airborne pollen released from July through October. As a member of subfamily Panicoideae within family Poaceae, crabgrass produces Group 1 beta-expansin allergens that trigger IgE-mediated sensitization in susceptible individuals. Although no WHO/IUIS-named allergens exist specifically for Digitaria and crabgrass is not included in most standard allergy panels, patients in any of the 48 contiguous US states can develop crabgrass sensitization through repeated summer and fall pollen exposure. The most characteristic diagnostic clue is grass-like hay fever symptoms persisting from July through October after conventional May through July grass season has passed.

Crabgrass and ragweed both pollinate in late summer and fall, and their symptoms are clinically identical — sneezing, nasal congestion, and itchy eyes — making the distinction dependent on testing rather than symptom pattern alone. The geographic and biological distinction is that crabgrass is a Poaceae grass producing Group 1 beta-expansin allergens, while ragweed (Ambrosia artemisiifolia) is an Asteraceae weed producing pectate lyase Amb a 1 proteins — completely unrelated allergen families with no cross-reactivity. Component testing measuring grass-specific IgE (Phl p 1, Johnson grass g10) and ragweed-specific IgE (Amb a 1) can clearly identify which allergen is responsible. Many patients are sensitized to both, meaning late-summer symptoms reflect co-sensitization rather than either allergen alone.

If your grass allergy symptoms worsen in August and September when you expected them to improve, crabgrass or another Panicoideae sour grass is a likely explanation. Conventional grass allergy testing and treatment focus on Pooideae species (Timothy, ryegrass, bluegrass), which peak in May through July. Crabgrass belongs to a different subfamily, Panicoideae, and pollinates from July through October. Patients sensitized to both Pooideae and Panicoideae grasses experience a prolonged season where spring symptoms are driven by sweet grasses and summer and fall symptoms are driven by sour grasses. If your immunotherapy was formulated using only Timothy and Pooideae species, it may be controlling spring symptoms while leaving the crabgrass-driven summer and fall symptoms untreated.

Crabgrass is present in all 48 contiguous US states, but the severity of pollen exposure and the length of the season vary by region. In southern states — Texas, Florida, Georgia, the Carolinas — the growing season is longer and crabgrass can germinate earlier and flower later, sometimes extending the pollen season from June through November. In northern states, the season is compressed into July through September, determined by frost timing. The two main species, large crabgrass (Digitaria sanguinalis) and smooth crabgrass (Digitaria ischaemum), are distributed throughout the range with somewhat different geographic emphases — smooth crabgrass is more prevalent in northern cool climates while large crabgrass dominates warmer regions. Regardless of region, the Panicoideae Group 5 absence that creates the diagnostic gap is identical across all crabgrass populations.

Yes, improving your lawn to reduce crabgrass density is one of the most effective localized exposure reduction strategies available for any grass pollen allergy. Unlike most inhalant allergens, crabgrass in your immediate residential environment can be meaningfully reduced through spring pre-emergent herbicide application, which prevents germination before the pollen season begins, combined with maintaining a thick turf that physically prevents crabgrass establishment. A lawn that is 80 percent crabgrass-free exposes you to significantly less pollen than a thin, crabgrass-infested lawn. That said, neighborhood and regional pollen from other lawns and open spaces limits total symptom reduction from lawn management alone — immunotherapy addressing Panicoideae sensitization is the complementary intervention that reduces reactivity to ambient pollen regardless of its source.

Crabgrass (Digitaria) and Johnson grass (Sorghum halepense) are different species but they belong to the same subfamily, Panicoideae, and are expected to have high cross-reactivity through shared Group 1 beta-expansin allergen homologs. This means patients sensitized to crabgrass are likely to also react to Johnson grass, and vice versa. The key clinical distinction is geographic distribution and plant habitat: crabgrass is a low-growing annual lawn weed found in all 48 states, while Johnson grass is a tall perennial noxious weed primarily along roadsides and agricultural margins in the South and East. Johnson grass has five WHO/IUIS-named allergens with excellent molecular characterization; crabgrass has zero named allergens. For immunotherapy purposes, Johnson grass extract serves as the Panicoideae representative that is expected to provide cross-reactive benefit for crabgrass sensitization.

Patients with both Pooideae and Panicoideae sensitization often report a characteristic two-phase grass allergy pattern. The first phase, driven by Pooideae grasses, runs May through July with sneezing, nasal congestion, and itchy eyes that respond well to antihistamines and nasal steroids. Symptoms ease in late July as Pooideae counts fall. Then, instead of the relief they expect, symptoms return or persist from August through October — the crabgrass phase — but may feel somewhat different because ambient pollen counts from crabgrass may be lower than the May through June Pooideae peak. The combined ragweed and crabgrass burden in August and September can make late summer feel like a second distinct allergy season for patients sensitized to multiple late-summer allergens simultaneously.

Yes, mowing a crabgrass-infested lawn during peak pollen season in July and August can significantly worsen allergy symptoms. When the mower blade passes through flowering crabgrass inflorescences, it mechanically disrupts the pollen-bearing structures and releases concentrated pollen clouds at ground level. The exposure during and immediately after mowing can substantially exceed ambient pollen counts measured at monitoring stations. For sensitized patients, post-mowing symptom flares with intense sneezing, rhinorrhea, and eye irritation are a characteristic pattern that should prompt evaluation for crabgrass sensitization. Practical solutions include mowing in late afternoon when daily pollen production has peaked and is declining, wearing a fitted face mask during mowing, showering immediately afterward, and timing mowing to before visible crabgrass inflorescences emerge in early July.

The symptomatic treatment of crabgrass allergy — nasal corticosteroids, antihistamines, antihistamine eye drops — is identical to treatment for any grass pollen allergy. The differences are in treatment timing and immunotherapy extract composition. Treatment must extend through October rather than ending in late July. For immunotherapy, the critical modification is ensuring a Panicoideae representative is included in the formulation: standard Timothy-based SLIT tablets (Grastek, Oralair) and Timothy-only SCIT vials provide incomplete coverage for Panicoideae sensitization because they lack Group 5-cross-reactive activity relevant to crabgrass. Custom multi-allergen SLIT drops that incorporate Johnson grass extract as the Panicoideae representative alongside Timothy provide comprehensive sweet and sour grass coverage. Patients on existing grass immunotherapy who still experience July through October symptoms should specifically ask about Panicoideae extract inclusion in their current formulation.

Without appropriate treatment, crabgrass allergy can progressively worsen over successive seasons. The mechanism is well-established for seasonal allergic rhinitis: each year of repeated allergen exposure without immunological tolerance induction reinforces the IgE-mediated sensitization, potentially lowering the pollen threshold required to trigger symptoms and increasing the severity of the inflammatory response. Additionally, untreated allergic nasal inflammation creates conditions that facilitate sensitization to additional allergens — patients who allow crabgrass allergy to persist untreated over several years frequently develop new sensitivities to ragweed, mold, and dust mites, compounding the total allergy burden beyond the original crabgrass sensitization. Allergen immunotherapy with Panicoideae-appropriate extracts addresses the root cause of the sensitization rather than simply suppressing symptoms year after year.